Carmen Mueller
Overview
Explore the profile of Carmen Mueller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tankel J, Patel D, Nevo Y, Najmeh S, Spicer J, Mulder D, et al.
Ann Surg Oncol
. 2023 Jul;
30(13):8182-8191.
PMID: 37436604
Background: Following left thoracoabdominal (LTA) esophagogastrectomy, gastrointestinal continuity can be re-established via esophagogastrostomy or esophagojejunostomy. We explored how the method of reconstruction impacted postoperative outcomes and quality of life (QoL)....
12.
Menon N, Guidozzi N, Chidambaram S, Puri A, Sounderajah V, Ferri L, et al.
Dis Esophagus
. 2023 May;
36(10).
PMID: 37158194
Large hiatus hernias with a significant paraesophageal component (types II-IV) have a range of insidious symptoms. Management of symptomatic hernias includes conservative treatment or surgery. Currently, there is no paraesophageal...
13.
Grou-Boileau F, Tankel J, Nevo Y, Najmeh S, Spicer J, Cools-Lartigue J, et al.
J Gastrointest Cancer
. 2023 Mar;
54(4):1292-1299.
PMID: 36988820
Purpose: Locoregional recurrence of esophageal carcinoma after neoadjuvant therapy and en bloc esophagectomy, although uncommon, is challenging to manage. Currently, there are no standard treatment approaches prompting many health care...
14.
Evaristo G, Katz A, Ramirez-GarciaLuna J, Issac M, Sangwan V, Thai D, et al.
Can J Surg
. 2023 Feb;
66(1):E79-E87.
PMID: 36792128
Background: It has recently been reported that mismatch repair (MMR) status and microsatellite instability (MSI) status in gastroesophageal carcinomas predict surgical, chemotherapeutic and immunotherapeutic outcomes; however, there is extensive variability...
15.
Sherwinter D, Boni L, Bouvet M, Ferri L, Hyung W, Ishizawa T, et al.
Surgery
. 2022 Nov;
172(6S):S29-S37.
PMID: 36427927
Background: Understanding the extent of tumor spread to local lymph nodes is critical to managing early-stage gastric cancer. Recently, fluorescence imaging with indocyanine green has been used to identify and...
16.
Tankel J, Soderstrom H, Reizine E, Artho G, Calderone A, Mueller C, et al.
J Gastrointest Surg
. 2022 Oct;
26(12):2417-2425.
PMID: 36214951
Background: Changes in the size and density of esophageal malignancy during neoadjuvant chemotherapy (NCT) may be useful in predicting overall survival (OS). The aim of this study was to explore...
17.
Katz A, Nevo Y, Luna J, Anchouche S, Tankel J, Caminsky N, et al.
Ann Thorac Surg
. 2022 Aug;
115(1):200-208.
PMID: 35926638
Background: Surgery, as part of a multimodal approach, offers the greatest chance of cure for esophageal cancer. However, esophagectomy is often perceived as having a lasting impact on quality of...
18.
Balvardi S, Semsar-Kazerooni K, Kaneva P, Mueller C, Vassiliou M, Al Mahroos M, et al.
Surg Endosc
. 2022 Aug;
37(3):2281-2289.
PMID: 35922607
Introduction: Self-review of recorded surgical procedures offers new opportunities for trainees to extend technical learning outside the operating-room. Valid tools for self-assessment are required prior to evaluating the effectiveness of...
19.
Donlon N, Moran B, Kamilli A, Davern M, Sheppard A, King S, et al.
Ann Surg
. 2022 Jul;
276(5):792-798.
PMID: 35876385
Background: The FLOT protocol and the CROSS trimodality regimen represent current standards in the management of locally advanced esophageal adenocarcinoma. In the absence of published Randomised Controlled Trial data, this...
20.
Cools-Lartigue J, Markar S, Mueller C, Hofstetter W, Nilsson M, Ilonen I, et al.
Ann Surg
. 2022 Jul;
276(5):799-805.
PMID: 35861351
Objective: To compare overall (OS) and recurrence-free survival (RFS) in esophageal adenocarcinoma patients with a pathologically complete response (pCR) following neoadjuvant chemotherapy (nCT) or neoadjuvant chemoradiotherapy (nCRT). Background: In the...